The basis of this article is to provide:
1. A brief overview of about Akorn Inc.
2. An analysis of Akorn's core business
3. Evaluation of sales, market/sector, and financials (2013 Q1 and Q2)
4. Opinionated conclusions and price targets
Akorn Inc. (NASDAQ: AKRX)
Akorn Inc. ("Akorn," "AKRX" or the "Company") is a generic pharmaceutical company with a market cap of roughly $1.6 billion (at time of writing). A quick analysis of Akorn reveals that the company has experienced substantial revenue growth over the past three years. Subsequently, Akorn has increased its share price from the $1.80 range to the $16 range (a total return of roughly 789%). Despite the significant increase in valuation, Akorn still remains...